Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» abelacimab
abelacimab
Anthos hails win over Xarelto with novel anticoagulant
Pharmaphorum
Mon, 09/18/23 - 09:56 am
Anthos Therapeutics
clinical trials
abelacimab
Xarelto
anticoagulants
atrial fibrillation
Anthos doubles down on its novel blood thinner
EP Vantage
Fri, 01/27/23 - 10:34 am
Anthos
Novartis
Factor XI inhibitor
bloodthinners
abelacimab
FDA grants fast track designation for Anthos’ cancer associated thrombosis therapy
Pharmaceutical Business Review
Mon, 07/11/22 - 10:26 am
Anthos Therapeutics
Factor XI inhibitor
abelacimab
fast track
FDA
cancer